Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans

被引:32
作者
Marsh, JB [1 ]
Welty, FK [1 ]
Schaefer, EJ [1 ]
机构
[1] Tufts Univ, USDA, Human Nutr Res Ctr Aging, Lipid Metab Lab, Boston, MA 02111 USA
关键词
D O I
10.1097/00041433-200006000-00006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amino acid precursors labelled with stable isotopes have been successfully used to explore the metabolism of the apolipoproteins of HDL. Some methodological and mathematical modelling problems remain, mainly related to amino acid recycling in a plasma protein such as apolipoprotein A-I with a long residence time (the reciprocal of the fractional catabolic rate) of 4-5 days, Apolipoprotein A-I, apolipoprotein E, and apolipoprotein A-IV in triglyceride-rich lipoproteins (containing chylomicrons, VLDL, and remnants) exhibit more complex kinetics, The small amounts of apolipoprotein A-I and of apolipoprotein A-IV in the triglyceride-rich lipoproteins have a residence time similar to that of the apolipoprotein A-I of HDL, In contrast, the apolipoprotein E in triglyceride-rich lipoproteins has been found to have an average residence time of 0.11 days. Diets low in saturated fat and cholesterol, which lower HDL levels, do so by decreasing the secretion of apolipoprotein A-I, with apolipoprotein A-II kinetics unaffected, Individuals with impaired glucose tolerance have a decreased residence time of apolipoprotein A-I but no change in secretion rate or in apolipoprotein A-II kinetics, This suggests a link between insulin resistance and the risk of atherosclerosis, In heterozygous familial hypercholesterolemia, both the fractional catabolic rate and the secretion rate of apolipoprotein A-I are increased, resulting in no change in the plasma level. Stable isotope studies have strengthened the evidence that triglyceride enrichment of HDL increases its catabolism Laboratory. Curr Opin Lipidol 11:261-266 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 39 条
[31]   THE EFFECTS OF ESTROGEN ADMINISTRATION ON PLASMA-LIPOPROTEIN METABOLISM IN PREMENOPAUSAL FEMALES [J].
SCHAEFER, EJ ;
FOSTER, DM ;
ZECH, LA ;
LINDGREN, FT ;
BREWER, HB ;
LEVY, RI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (02) :262-267
[32]   Impact of gender on the metabolism of apolipoprotein A-I in HDL subclasses LpAI and LpAI:AII in older subjects [J].
Tilly-Kiesi, M ;
Lichtenstein, AH ;
Joven, J ;
Vilella, E ;
Cheung, MC ;
Carrasco, WV ;
Ordovas, JM ;
Dolnikowski, G ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (12) :3513-3518
[33]   Dietary restriction of saturated fat and cholesterol decreases HDL apoA-I secretion [J].
Vélez-Carrasco, W ;
Lichtenstein, AH ;
Welty, FK ;
Li, ZL ;
Lamon-Fava, S ;
Dolnikowski, GG ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (04) :918-924
[34]   Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [2H3] leucine in middle-aged and elderly men and women [J].
Velez-Carrasco, W ;
Lichtenstein, AH ;
Li, ZL ;
Dolnikowski, GG ;
Lamon-Fava, S ;
Welty, FK ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (03) :801-806
[35]  
Vélez-Carrasco W, 1999, J LIPID RES, V40, P1695
[36]  
VERGES B, 1994, J LIPID RES, V35, P2280
[37]   NEW IN-VIVO TECHNIQUES FOR MEASURING LIPOPROTEIN METABOLISM [J].
WATSON, TDG .
CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (03) :182-186
[38]   Human apolipoprotein (apo) B-48 and apoB-100 kinetics with stable isotopes [J].
Welty, FK ;
Lichtenstein, AH ;
Barrett, PHR ;
Dolnikowski, GG ;
Schaefer, EJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :2966-2974
[39]  
ZECH LA, 1983, J LIPID RES, V24, P60